Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 55.76% | 0.00% | 16.21% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -31.03% | 0.00% | -22.62% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 75.56% | 0.00% | 15.38% | 0.00% |
| Change in Net Operating Assets | 0.00% | -144.19% | 0.00% | 57.40% | 0.00% |
| Cash from Operations | 0.00% | -71.90% | 0.00% | 325.51% | 0.00% |
| Capital Expenditure | 0.00% | 31.14% | 0.00% | -3,600.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -1,109.87% | 0.00% | -3,600.00% | 0.00% |
| Total Debt Issued | 0.00% | 38.19% | 0.00% | 352.63% | 0.00% |
| Total Debt Repaid | 0.00% | -51.60% | 0.00% | 14.99% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -85.40% | 0.00% | -65.96% | 0.00% |
| Cash from Financing | 0.00% | -80.51% | 0.00% | -60.46% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 154.00% | 0.00% | 60.32% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -418.69% | 0.00% | -36.46% | 0.00% |